STOCK TITAN

Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) announced its participation in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023. The management team will present at 9:00 a.m. Eastern Time, and the presentation can be accessed via a live webcast. A replay will be available for two weeks post-event on Inspire's investor website. Inspire specializes in innovative solutions for obstructive sleep apnea, with its Inspire therapy being the first FDA-approved neurostimulation technology for treating moderate to severe cases. For more details, visit www.inspiresleep.com.

Positive
  • None.
Negative
  • None.

MINNEAPOLIS, March 07, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023.

Inspire is scheduled to present at 9:00 a.m. Eastern Time. The presentation will be accessible via a live webcast here.

A webcast replay of the presentation will be available for two weeks following the presentation in the Event Archive section of Inspire’s Investor website at https://investors.inspiresleep.com.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443


FAQ

What is the date of Inspire Medical Systems' presentation at the KeyBanc Capital Markets Investor Forum?

Inspire Medical Systems will present on March 21, 2023.

What time is Inspire's presentation at the investor forum scheduled?

The presentation is scheduled for 9:00 a.m. Eastern Time.

Where can I watch the live webcast of Inspire's presentation?

The live webcast can be accessed through the KeyBanc Capital Markets event page.

How long will the webcast replay of Inspire's presentation be available?

The webcast replay will be available for two weeks following the presentation.

What technology does Inspire Medical Systems focus on for sleep apnea treatment?

Inspire specializes in FDA-approved neurostimulation technology for obstructive sleep apnea.

Inspire Medical Systems, Inc.

NYSE:INSP

INSP Rankings

INSP Latest News

INSP Stock Data

5.64B
29.36M
1.95%
113.89%
6.52%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
GOLDEN VALLEY